SARASOTA, Fla. - November 23, 2020 - (Newswire.com)
CEOs, entrepreneurs, and business owners are optimistic about the effectiveness of recent vaccine trials within the U.S., feeling that their businesses wouldn’t be able to endure a second shutdown in response to rising coronavirus cases according to PressRelase.com. Through simple and affordable press release distribution, PressRelease.com helps support businesses in their pursuit to grow brand awareness, website traffic, and leads, even amid a second wave of the pandemic.
“It’s amazing news for everyone. A number of our customers have expressed relief that these trials are so effective,” says Erik Rohrmann, COO of PressRelease.com. “Aside from the obvious, it has big implications for businesses. The possibility of an effective vaccine in the near future is the first step towards the possibility of returning to the normal we are accustomed to.”
Earlier this month, two American pharmaceutical companies, Pfizer and Moderna, announced their COVID-19 vaccines both showed over 90% effectiveness in clinical trials. The news comes as positive COVID cases reach 11.8 million in the United States. Drugmakers are expected to seek regulatory clearance in the near future, leaving many businesses optimistic about the impact it could have on other industries.
Partnerships with Newswire and Accesswire have allowed PressRelease.com to provide businesses more value, and capitalize on the potential opportunities that come with widespread vaccination. PressRelease.com connects businesses with local, state and national audiences through wire distribution to prominent business networks including MarketWatch, Bloomberg, Yahoo! Finance, Morningstar, CBS, ABC, FOX and NBC.
PressRelease.com helps businesses and their leaders maximize business communications through simple and effective press release distribution services. To learn more about how to create newfound value through press release content, visit PressRelease.com.
About PressRelease.com
PressRelease.com provides simple, affordable press release distribution services to public and private companies through the most comprehensive networks and 1.8M media contacts.
Contact Information:
PressRelease.com
Media Relations
Office: 800-998-2927
Press Release Service by Newswire.com
Original Source: Optimism From Early Vaccine Trials is an Encouraging Sign for Many Businesses, According to PressRelease.com
